Characteristics of the Guideline for the Management of Hyperuricemia and Gout, 2<sup>nd</sup> edition

DOI Web Site 1 Citations

Bibliographic Information

Other Title
  • 高尿酸血症・痛風の治療ガイドライン (第2版) の特色と活用法
  • Characteristics of the Guideline for the Management of Hyperuricemia and Gout, 2nd edition

Search this article

Description

 Revised version of the Guideline for the Management of Hyperuricemia and Gout,2nd edition has been delivered in jan. 2010. Followings are the main point of guidelines: (1)Hyperuricemia is a major pathogenic factor for urate deposition diseases (gouty arthritis, renal disorder, etc.). It is defined as a disease condition showing a serum urate level exceeding 7.0mg/dl, regardless of sex and age. (2)In women, the risks of lifestyle-related diseases increase with increase in serum urate level, even when it is not more than 7.0mg/dl. Examination for possible underlying diseases and lifestyle guidance should be given; however, drug therapy with urate-lowering drugs is not indicated. (3) Hyperuricemia is broadly classified into the following 3 types: uric acid-overproduction type, uric acid-underexcretion type and combined type. The uric acid clearance rate and creatinine clearance rate are determind for the classification. (4) Hyperuricemia and gout are lifestyle-related diseases. Education and proper guidance aimed at modifying the patients lifestyle play a crucial role in improving the clinical course of the disease with or without drug therapy. (5) Lifestyle modification consists of three parts: nutrition therapy, restriction of alcohol consumption, and recommendation for physical training. Modest weight loss has been shown to reduce serum urate level.

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top